Interactive Features

Test Your Knowledge

Quiz: Which Treatment Received FDA Approval for Metastatic Urothelial Carcinoma?

11/03/2020

What treatment was approved by the FDA for metastatic urothelial carcinoma in June 2020?

What treatment was approved by...

11/03/2020

Oncology

Test Your Knowledge

Quiz: Does Pembrolizumab Yield Promising Results in Advanced Urothelial Cancer?

09/10/2020

True or False: Pembrolizumab provided a durable clinical response in cisplatin-ineligible patients with advanced urothelial carcinoma and is associated with prolonged OS.

True or False: Pembrolizumab...

09/10/2020

Oncology

Test Your Knowledge

Quiz: Is Enfortumab Vedotin an Effective Therapy for Metastatic Urothelial Cancer?

06/22/2020

True or False: Enfortumab vedotin monotherapy has not been shown to yield durable responses in patients with metastatic urothelial cancer.

True or False: Enfortumab...

06/22/2020

Oncology

Test Your Knowledge

Quiz: Is Teratoma a Prognostic Factor in Testicular Germ Cell Tumors?

05/05/2020

True or false: Teratoma is a prognostic factor in patients with metastatic testicular germ cell tumors.

True or false: Teratoma is a...

05/05/2020

Oncology

Test Your Knowledge

Quiz: Adjuvant vs Neoadjuvant Chemo for Muscle-Invasive Bladder Cancer

03/06/2020

True or False: Patients with muscle-invasive bladder cancer have increased overall survival with adjuvant versus neoadjuvant chemo.

True or False: Patients with...

03/06/2020

Oncology

Test Your Knowledge

Quiz: Adding THOLR or TUR to Epirubicin After Surgery for Bladder Cancer

02/12/2020

True or False: Combining transurethral holmium laser resection or transurethral electrocision with intravesical epirubicin within 2 weeks of surgery has been shown to be safe and effective for patients with bladder cancer.

True or False: Combining...

02/12/2020

Oncology

Test Your Knowledge

Quiz: Can Education and Rehab Improve QoL in Muscle Invasive Bladder Cancer?

01/06/2020

True or False: Education and rehabilitation programs have shown no benefits in the post-surgery management of patients with muscle-invasive bladder cancer.

True or False: Education and...

01/06/2020

Oncology

Test Your Knowledge

Quiz: Effect of New Long Non-Coding RNA on Bladder Cancer

12/20/2019

Study findings suggest that the novel long non-coding (lnc)RNA KMU15 could _____ the proliferation and progression of bladder cancer.

Study findings suggest that the...

12/20/2019

Oncology

Test Your Knowledge

Quiz: Urinary Calprotectin as a Bladder Cancer Tumor Marker

12/20/2019

True or False: Urinary calprotectin cannot be used as a specific tumor marker for bladder cancer.

True or False: Urinary...

12/20/2019

Oncology

Test Your Knowledge

Quiz: Does YAP1/mTOR Interaction Inhibit Bladder Cancer Progression?

12/19/2019

True or False: The interaction between YAP1 and mTOR slows down disease progression in patients with bladder cancer.

True or False: The interaction...

12/19/2019

Oncology

Recent News

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology

News

Mirdametinib for Adult and Pediatric Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

11/12/2024

Allison Casey ;

According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...

According to a phase 2b trial,...

11/12/2024

Oncology

News

Epirubicin Plus Cyclophosphamide and Docetaxel Reduces Long-Term Risk of Recurrence for Patients With TOP2A Normal Early Breast Cancer

11/12/2024

Stephanie Holland ;

According to final results from the DBCG 07-READ trial, the addition of epirubicin to cyclophosphamide and docetaxel reduced long-term risk of breast cancer recurrence among patients with TOP2A normal early breast cancer.

According to final results from...

11/12/2024

Oncology

News

Pembrolizumab Plus Chemotherapy For Patients With High-Risk Endometrial Cancer

11/11/2024

Allison Casey ;

According to results from a phase 3 trial, pembrolizumab plus chemotherapy did not improve DFS among patients with high-risk endometrial cancer. However, there may be a benefit among patients with mismatch report-deficient disease.

According to results from a...

11/11/2024

Oncology

FDA Approval

FDA Grants Approval to Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia

11/08/2024

On November 8, 2024, the FDA approved CD19-directed genetically modified autologous T cell immunotherapy obecabtagene autoleucel for the treatment of patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

On November 8, 2024, the FDA...

11/08/2024

Oncology

News

Naporafenib in Combination With Rineterkib or Tremetinib for KRAS- or BRAF-Mutant Non-Small Cell Lung Cancer

11/07/2024

Allison Casey ;

While naporafenib plus rineterkib and naporafenib plus trametinib both had acceptable safety profiles, antitumor activity was limited among patients with KRAS-/BRAF-mutant non-small cell lung cancer.

While naporafenib plus...

11/07/2024

Oncology

News

Addition of Concurrent Thoracic Radiotherapy to First-Line TKI Therapy Improves Survival for Patients With EGFR-Mutated Non-Small Cell Lung Cancer

11/06/2024

Stephanie Holland ;

According to results from a phase 3 trial, the addition of concurrent thoracic radiotherapy to first-line icotinib improved survival among patients with EGFR-mutated oligo-organ metastatic non-small cell lung cancer.

According to results from a...

11/06/2024

Oncology

News

Ipilimumab After PD-1 Inhibition Failure Among Patients With Metastatic Melanoma

11/05/2024

Allison Casey ;

A single-center real-world study found the use of ipilimumab in the second-line was an effective therapy for patients with metastatic BRAF/NRAS-wildtype metastatic melanoma without brain metastases.

A single-center real-world study...

11/05/2024

Oncology